Developing countries also fear the huge costs associated with greener technologies, which will be unbearable by their domestic industries. It could make their goods uncompetitive in western markets.

However, the Doha declaration does not take a decision on whether countries with insufficient or no manufacturing capacities in the pharmaceutical sector will be allowed to import generic drugs to

The European Union buckles under the pressure of the developing countries to reduce agricultural subsidies